Be a Part of the Major Health Revolution!

Irritable bowel syndrome (IBS) is a common condition that affects the digestive system and approximately 10% of the world population suffer from it. There are 30 million people in the US who suffer from IBS and spend on average $6K annually to manage it.
There is no standardized treatment protocol for IBS and we are the first company to offer a personalized solution for IBS. Our cutting-edge technology is based on microbiome analysis, artificial intelligence algorithms and personalized solutions.
Our fundraising round is open and we are looking for investors.
Fill out the form and click submit to become a part of this revolution.



Be partner with Enbiosis

Fill out the form now to contact us and learn more about our fundraising tour!

    Input this code: captcha